Pharma firm Merck & Co., Inc. (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to a sharp fall in revenues.
First-quarter sales decreased 9% year-over-year to $14.5 billion, hurt mainly by a double-digit fall in sales at the core pharmaceuticals division.
As a result, adjusted earnings dropped to $1.40 per share in the three-month period from $2.14 per share a year earlier. Unadjusted profit declined to $2.82 billion or $1.11 per share from $4.31 billion or $1.70 per share in the year-ago quarter.
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw
eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and